Bonus BioGroup Ltd. (BONS.TA)
ILA 9.1
(0.0%)
ILA 9.1
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -28.52 Million ILS | 26.29% |
| 2022 | -38.7 Million ILS | 57.03% |
| 2021 | -90.07 Million ILS | -309.05% |
| 2020 | -22.02 Million ILS | 0.98% |
| 2019 | -22.24 Million ILS | -18.71% |
| 2018 | -18.73 Million ILS | 7.24% |
| 2017 | -20.19 Million ILS | -25.87% |
| 2016 | -16.04 Million ILS | -19.22% |
| 2015 | -13.45 Million ILS | -20.09% |
| 2014 | -11.2 Million ILS | -15.52% |
| 2013 | -9.7 Million ILS | 46.02% |
| 2012 | -17.97 Million ILS | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -7.05 Million ILS | 10.98% |
| 2024 Q1 | -7.92 Million ILS | -5.61% |
| 2023 Q4 | -7.5 Million ILS | -11.83% |
| 2023 Q3 | -6.7 Million ILS | -0.12% |
| 2023 FY | -28.52 Million ILS | 26.29% |
| 2023 Q1 | -7.61 Million ILS | 23.89% |
| 2023 Q2 | -6.7 Million ILS | 12.01% |
| 2022 Q3 | -16.1 Million ILS | -204.18% |
| 2022 Q2 | -5.29 Million ILS | 27.53% |
| 2022 FY | -38.7 Million ILS | 57.03% |
| 2022 Q1 | -7.3 Million ILS | 54.37% |
| 2022 Q4 | -10 Million ILS | 37.85% |
| 2021 Q1 | -44.95 Million ILS | -501.44% |
| 2021 Q3 | -11.52 Million ILS | 34.44% |
| 2021 Q4 | -16 Million ILS | -38.85% |
| 2021 FY | -90.07 Million ILS | -309.05% |
| 2021 Q2 | -17.58 Million ILS | 60.89% |
| 2020 Q2 | -4.97 Million ILS | 20.57% |
| 2020 FY | -22.02 Million ILS | 0.98% |
| 2020 Q4 | -7.47 Million ILS | -126.31% |
| 2020 Q3 | -3.3 Million ILS | 33.63% |
| 2020 Q1 | -6.26 Million ILS | -33.52% |
| 2019 Q1 | -7.58 Million ILS | -37.19% |
| 2019 Q2 | -5.23 Million ILS | 30.96% |
| 2019 Q3 | -4.72 Million ILS | 9.91% |
| 2019 Q4 | -4.69 Million ILS | 0.57% |
| 2019 FY | -22.24 Million ILS | -18.71% |
| 2018 Q4 | -5.53 Million ILS | -30.57% |
| 2018 Q3 | -4.23 Million ILS | -7.19% |
| 2018 Q2 | -3.95 Million ILS | 21.21% |
| 2018 Q1 | -5.01 Million ILS | -35.75% |
| 2018 FY | -18.73 Million ILS | 7.24% |
| 2017 Q2 | -3.59 Million ILS | -1.24% |
| 2017 Q1 | -3.55 Million ILS | -7.05% |
| 2017 Q3 | -9.35 Million ILS | -159.99% |
| 2017 FY | -20.19 Million ILS | -25.87% |
| 2017 Q4 | -3.69 Million ILS | 60.49% |
| 2016 Q3 | -6.32 Million ILS | -97.47% |
| 2016 Q4 | -3.31 Million ILS | 47.49% |
| 2016 Q1 | -3.2 Million ILS | 27.73% |
| 2016 Q2 | -3.2 Million ILS | 0.12% |
| 2016 FY | -16.04 Million ILS | -19.22% |
| 2015 FY | -13.45 Million ILS | -20.09% |
| 2015 Q2 | -2.94 Million ILS | -13.95% |
| 2015 Q1 | -2.58 Million ILS | 10.97% |
| 2015 Q4 | -4.43 Million ILS | -27.19% |
| 2015 Q3 | -3.48 Million ILS | -18.24% |
| 2014 Q1 | -3.18 Million ILS | 1.85% |
| 2014 Q4 | -2.9 Million ILS | -34.77% |
| 2014 Q3 | -2.15 Million ILS | 27.05% |
| 2014 Q2 | -2.95 Million ILS | 7.19% |
| 2014 FY | -11.2 Million ILS | -15.52% |
| 2013 FY | -9.7 Million ILS | 46.02% |
| 2013 Q1 | -2.12 Million ILS | 0.0% |
| 2013 Q4 | -3.24 Million ILS | -31.68% |
| 2013 Q3 | -2.46 Million ILS | -31.96% |
| 2013 Q2 | -1.86 Million ILS | 11.97% |
| 2012 FY | -17.97 Million ILS | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Matricelf Ltd | -12.48 Million ILA | -128.488% |